Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers
Clinical trial NCT05993325 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05993325
- Sponsor
- Cellid Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-03-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.